Question · asked by 1 review

Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo: Number of days of treatment with opioid analgesics

Population
Adults with cancer receiving treatment
Intervention
Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous
Comparison
placebo
Outcome
Number of days of treatment with opioid analgesics

Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in number of days of treatment with opioid analgesics compared with placebo; GRADE not reported.

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs Placebo
Number of days of treatment with opioid analgesics · Adults with cancer receiving treatment · BMT/SCT after conditioning for haematological cancers
Keratinocyte growth factor (KGF; palifermin or repifermin),… showed no clear difference in number of days of treatment with opioid analgesics compared with placebo; GRADE not reported.
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and… (2017) · Cochrane All outcomes
MD -1.41 [-3.33, 0.51]2 studies · 323 participantsGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors
2017 · Cochrane All outcomes
2017-05Not listedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.